- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in Health
Zydus Wellness Q1 Net Profit Up 11 % At Rs 89 Crore
Consolidated revenue from operations totalled Rs 537 crore while earnings before interest, depreciation and tax (EBIDTA) were at Rs 122 crore.
Read MoreExperts develop new risk tool for cardiac arrest patients: Study
Experts develop new risk tool for cardiac arrest patients: Study
Read MoreGilead Raises Sales Outlook To Include COVID-19 Treatment Remdesivir
Gilead's second-quarter sales fell nearly 10% from a year earlier to $5.1 billion, short of the average analyst estimate of $5.3 billion, according to Refinitiv.
Read MoreMore Than 1 Million Patients Recovered From COVID-19 Till Now In India: Health Ministry
"More than 1 million people have recovered from COVID-19 in the country. This landmark recovery has been achieved because of the selfless work and dedication of our doctors, nurses and frontline workers,"
Read MoreMost women treated in New York City for gynecologic cancers not at increased risk of death from COVID-19: Study
Most women treated in New York City for gynecologic cancers not at increased risk of death from COVID-19: Study
Read MoreNew drug targets for lethal brain cancer discovered
New drug targets for lethal brain cancer discovered
Read MoreGSK Profit Misses As Shingrix Disappoints, Stockpiling Eases
Turnover fell 3% to 7.62 billion pounds in the three months ended June 30 on a constant currency basis, while adjusted earnings stood at 19.2 pence per share
Read MoreDr Reddy's Net Profit Falls 13 % To Rs 579 Cr In June Quarter
The revenue went up 15 per cent at Rs 4,418 crore as against Rs 3,844 crore while earnings before interest, taxes, depreciation and amortisation (EBITDA) were up 2.5 per cent at Rs 1,162 crore in Q1 FY21 as compared to Rs 1,134 crore in Q1 FY20.
Read MoreRoche Bid To Retool Arthritis Drug For COVID-19 Fails
Pharmaceutical companies have been racing to develop treatments against the COVID-19 pandemic that has claimed nearly 660,000 lives and crippled economies.
Read MoreExposure to environmental chemicals may disrupt sleep during menopause
Exposure to environmental chemicals may disrupt sleep during menopause
Read MorePediatric experts offer tips for children's mental health in transition back to school
Pediatric experts offer tips for children's mental health in transition back to school
Read MorePessimistic outlook on life linked to life expectancy
Pessimistic outlook on life linked to life expectancy
Read MorePfizer Profit Falls 32% As Global Trial Of COVID-19 Vaccine Candidate Begins
The U.S. drugmaker said net income fell to $3.43 billion, or 61 cents per share, in the quarter, from $5.05 billion, or 91 cents per share, a year earlier.
Read MoreAfter Early Hype, Japan's Homegrown COVID-19 Drug Hope Avigan Faces Rocky Future
Interest in Avigan, developed more than 20 years ago, soared in March after a Chinese official said it appeared to help patients recover from COVID-19.
Read More